eQCM(R) software Selected by Ricerca to Optimize Compliance and Quality Business Process Automation

    QUEBEC CITY, July 30 /CNW Telbec/ - Amadeus, a division of Decimal, a
company specialized in business solutions and professional services in
corporate performance, quality and compliance management today announced that
Ricerca Biosciences, LLC, a CRO that delivers robust preclinical contract drug
discovery and development services to US biotechnology and pharmaceutical
companies, has selected Amadeus' eQCM(R) software platform to automate and
manage its quality and compliance management program.
    Compliant with FDA regulations including GLP and cGMP and meeting AALAC
and IACUC requirements, Ricerca needed to meet the ever changing regulatory
landscape by efficiently automating its data-driven workflow and critical
business processes.
    With eQCM(R), Ricerca now has a single and robust solution that enables
it to electronically create, manage and securely store all content, records,
dashboards and advanced reports. eQCM(R) software will enable Ricerca to
handle among others nonconformance, Corrective Action and Preventive Action
(CAPA) as well as internal and external audits, customer complaints and
document management.
    "Amadeus' software emerged from our selection process as the optimal
candidate for meeting our numerous needs" said Stephen Rogenthien, Manager of
GLP Operations for Ricerca. "In order to support our commitment to high levels
of quality and compliance for our clients, it was fundamental for Ricerca to
select and purchase a software package that allowed us to meet that
commitment" he said.
    "Building upon renowned strengths, like usability, flexibility,
intuitiveness and reliability and extending those characteristics to new
functionalities and improvements as our In-Control Process Statistics page or
powerful systems tasks, to name a few capabilities, our quality and compliance
technology platform significantly increases operational efficiency and
performance" said Pierre-François Isabel, Vice-President of Amadeus, a
division of Decimal. "We continue to be recognized as a first-class player,"
he said.

    About Ricerca

    Ricerca is the only North American CRO to offer the unique IP-INDSM
concept to pharmaceutical and biotechnology companies. The site encompasses
all discovery and development services required to bring a target or drug
candidate to a complete IND submission. The ability to perform both chemistry
(medicinal chemistry, process chemistry, cGMP API kilo-lab and pilot plant
production, complete analytical) and biology (DMPK, ADME, full toxicology,
safety pharmacology, animal efficacy models, bioanalytical) as well as report
writing and regulatory services at one site makes Ricerca the provider of
choice for virtual, small, and medium-sized pharmaceutical companies seeking a
successful IND submission.

    About Decimal

    DECIMAL is engaged in the design of specialized solutions in the area of
corporate performance management. Most notably, the company operates in the
areas of budget planning, strategic cost management, profitability analysis,
governance and business intelligence. The new division of Decimal, Amadeus,
provides quality and regulatory compliance management solutions in life
sciences, manufacturing and financial services.
    DECIMAL offers a vast array of consulting services and a Research &
Development team that has developed a world class software solution in the
activity based management and budgeting area (ABM). More information can be
found on DECIMAL at www.decimal.ca

For further information:

For further information: Isabelle Rivoal, Marketing and Communications
Director, Amadeus, a division of DECIMAL, (418) 525-0606, ext. 2231,

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890